Barrett's esophagus and esophageal cancer;Esófago de Barrett y cáncer de esófago

Gastroenterologia y Hepatologia

Volumn 29, Issue SUPPL. 3, 2006, Pages 62-66

  Castells, Antoni ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Barrett's esophagus; Diagnosis; Esophageal cancer; Photodynamic therapy

Indexed keywords

BARRETT ESOPHAGUS; DISEASE ASSOCIATION; DYSPLASIA; ENDOSCOPY; ESOPHAGUS CANCER; FOLLOW UP; HUMAN; IMAGING; INCIDENCE; PHOTODYNAMIC THERAPY; RAMAN SPECTROMETRY; REVIEW; TREATMENT RESPONSE;

EID: 34547744372     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1157/13098297     Document Type: Review

References (20)

1. Daly JM, Fry WA, Little AG, Winchester DP, McKee RF, Stewart AK, et al. Esophageal cancer: results of a American College of Surgeons Patient Care Evaluation Study. J Am Coll Surg. 2000;190:562-72.
2. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349:2241-52.
3. Rustgi AK. Gastrointestinal cancers. Philadelphia: Saunders; 2003.
4. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825-31.
5. Spechler SJ. Barrett's esophagus: an overrated cancer risk factor. Gastroenterology. 2000;119:587-9.
6. Wijnhoven BP, Tilanus HW, Dinjens WN. Molecular biology of Barrett's adenocarcinoma. Ann Surg. 2001;233:322-37.
7. Puli SR, Rastogi A, Mathur S, Bansal A, Sharma P. Development of esophageal adenocarcinoma in patients with Barrett's esophagus and high grade dysplasia undergoing surveillance: a meta-analysis and systematic review. Gastrointest Endosc. 2006;63:AB83.
8. Pellisé M, Llach J, Bordas JM. Técnicas endoscópicas emergentes. La llegada de la histología virtual. Gastroenterol Hepatol. 2005;28:641-8.
9. Bittinger M, Probst A, Jechart G, Arnholdt H, Messmann H. Zoom-narrow band imaging as a tool for the detection of Barrett metaplasia-Helpful or unnecessary? Gastrointest Endosc. 2006;63:AB90.
10. Wong Kee Song LM, Molckovosky A, Wang K, Buttar N, Burgart L, Wilson B, et al. Diagnostic accuracy of Raman spectroscopy for the classification of dysplastic lesions in Barrett's esophagus. Gastrointest Endosc. 2006;63:AB90.
11. Puli SR, Westhoff B, Shaheen NJ, Wei J, Slehria S, Bansal A, et al. Incidence of esophageal adenocarcinoma after endoscopic ablative therapy for Barrett's esophagus: a systematic review and meta-analysis. Gastroenterology. 2006;130:A455.
12. Overholt B, Wang K, Burdick S, Lightdale C, Kimmey M, Nava H, et al. A 5-year randomized phase III trial of efficay and safety of photodynamic therapy using porfimer sodium in high-grade dysplasia in Barrett's esophagus. Gastrointest Endosc. 2006;63:AB84.
13. Overholt BF, Lightdale CJ, Wang KK, Canto MI, Burdick S, Haggitt RC, et al; International Photodynamic Group for High-Grade Dysplasia in Barrett's Esophagus. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc. 2005;62:488-98.
14. Schembre D, Huang J, Felisky C, Cantone N, Low D. Endotherapy versus esophagectomy for Barrett's esophagus with highgrade dysplasia or intramucosal carcinoma: a review of outcomes. Gastrointest Endosc. 2006;63:AB85.
15. Prasad G, Wang K, Kevin HC, Brankley S, Buttar NS, Wongkeesong LM, et al. Biomarkers in the therapy of Barrett's esophagus with high-grade dysplasia. Gastroenterology. 2006;130:8.
16. Peters FP, Van Baal JW, Rygiel AM, Curvers WL, Rosmolen WD, Fockens P, et al. Stepwise endoscopic resection of the whole Barrett's esophagus in patients with early neoplasia effectively removes all genetic alterations from the esophageal epithelium. Gastroenterology. 2006;130:129.
17. Allum WH, Griffin SM, Watson A, Colin-Jones D; Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland; British Society of Gastroenterology; British Association of Surgical Oncology. Guidelines for the management of oesophageal and gastric cancer. Gut. 2002;50:1-23.
18. Oyama T, Hotta K. Endoscopic submucosal dissection for early esophageal cancer. Gastrointest Endosc. 2006;63:AB84.
19. Leonard GD, McCaffrey JA, Maher M. Optimal therapy for oesophageal cancer. Cancer Treat Rev. 2003;29:275-82.
20. Chang KJ, Senzer N, Swisher S, Reid T, Mauer A, Posner M, et al. Multicenter clinical trial using endoscopy and endoscopic ultrasound guided fine needle injection of anti-tumor agen (TNFerade) in patients with locally advanced esophageal cancer. Gastrointest Endosc. 2006;63:AB84.